Unraveling the complex relationships between anxiety, depression, and quality of life in schizophrenia: a network analysis study.

Saved in:
Bibliographic Details
Title: Unraveling the complex relationships between anxiety, depression, and quality of life in schizophrenia: a network analysis study.
Authors: Wu, Peiyi (AUTHOR), Wang, Yucheng (AUTHOR), Zhou, Yang (AUTHOR), Xu, Yixiao (AUTHOR), Zhang, Huanrui (AUTHOR), Li, Zijia (AUTHOR), Tang, Yanqing (AUTHOR)
Source: European Archives of Psychiatry & Clinical Neuroscience. Apr2026, Vol. 276 Issue 3, p937-946. 10p.
Subjects: Schizophrenia, Anxiety, Individualized medicine, Therapeutics, Quality of life, Symptom burden, Data analysis, Mental depression
Abstract: This study utilized network analysis to explore the intricate relationships between anxiety, depression, and quality of life in a cohort of hospitalized schizophrenia patients. Through a cross-sectional design, the investigation aimed to identify key symptoms and bridge connections to inform tailored clinical interventions and improve patient well-being. Symptom severity was measured using the Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, and Schizophrenia Quality of Life Scale, with network analysis elucidating central nodes and bridging symptoms within the patient sample of 1328 individuals. Findings revealed psychic anxiety, insomnia, and depressed mood as pivotal within the network, significantly impacting overall symptomatology and quality of life. Furthermore, symptoms such as tension and fears were identified as essential connectors among different symptom domains, highlighting potential intervention targets. The study underscores the complex dynamics between anxiety, depression, and quality of life in schizophrenia, advocating for an integrated treatment approach that focuses on critical symptoms to enhance overall well-being. This approach suggests a paradigm shift towards personalized care in schizophrenia management, aiming to optimize outcomes by addressing the root of symptom networks. [ABSTRACT FROM AUTHOR]
Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Description
Abstract:This study utilized network analysis to explore the intricate relationships between anxiety, depression, and quality of life in a cohort of hospitalized schizophrenia patients. Through a cross-sectional design, the investigation aimed to identify key symptoms and bridge connections to inform tailored clinical interventions and improve patient well-being. Symptom severity was measured using the Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, and Schizophrenia Quality of Life Scale, with network analysis elucidating central nodes and bridging symptoms within the patient sample of 1328 individuals. Findings revealed psychic anxiety, insomnia, and depressed mood as pivotal within the network, significantly impacting overall symptomatology and quality of life. Furthermore, symptoms such as tension and fears were identified as essential connectors among different symptom domains, highlighting potential intervention targets. The study underscores the complex dynamics between anxiety, depression, and quality of life in schizophrenia, advocating for an integrated treatment approach that focuses on critical symptoms to enhance overall well-being. This approach suggests a paradigm shift towards personalized care in schizophrenia management, aiming to optimize outcomes by addressing the root of symptom networks. [ABSTRACT FROM AUTHOR]
ISSN:09401334
DOI:10.1007/s00406-025-02011-1